Supriya Lifescience Limited (BOM:543434)
India
· Delayed Price · Currency is INR 728.15
+3.95 (0.55%)
At close: Jul 2, 2025
Supriya Lifescience Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2018 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2018 - 2020 |
Operating Revenue | 6,965 | 5,704 | 4,609 | 5,300 | 3,912 | Upgrade
|
| 6,965 | 5,704 | 4,609 | 5,300 | 3,912 | Upgrade
| |
Revenue Growth (YoY) | 22.11% | 23.74% | -13.04% | 35.49% | 22.25% | Upgrade
|
Cost of Revenue | 2,112 | 2,322 | 1,961 | 2,035 | 1,329 | Upgrade
|
Gross Profit | 4,853 | 3,381 | 2,649 | 3,266 | 2,583 | Upgrade
|
Selling, General & Admin | 805.19 | 862.26 | 730.21 | 655.81 | 501.41 | Upgrade
|
Other Operating Expenses | 1,440 | 758.61 | 628.48 | 465.44 | 350.31 | Upgrade
|
Operating Expenses | 2,450 | 1,779 | 1,477 | 1,222 | 919.33 | Upgrade
|
Operating Income | 2,404 | 1,602 | 1,172 | 2,043 | 1,664 | Upgrade
|
Interest Expense | -16.86 | -51.49 | -30.84 | -41.98 | -40.8 | Upgrade
|
Interest & Investment Income | - | 83.57 | 95.16 | 70.94 | 49.91 | Upgrade
|
Other Non Operating Income (Expenses) | 98.15 | 0.01 | -0.02 | 0.1 | 0.13 | Upgrade
|
EBT Excluding Unusual Items | 2,485 | 1,635 | 1,236 | 2,072 | 1,673 | Upgrade
|
Gain (Loss) on Sale of Investments | - | 22.4 | - | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | -1.11 | - | - | Upgrade
|
Pretax Income | 2,485 | 1,657 | 1,235 | 2,072 | 1,673 | Upgrade
|
Income Tax Expense | 605.23 | 465.76 | 336.3 | 554.35 | 437.16 | Upgrade
|
Net Income | 1,880 | 1,191 | 898.57 | 1,518 | 1,236 | Upgrade
|
Net Income to Common | 1,880 | 1,191 | 898.57 | 1,518 | 1,236 | Upgrade
|
Net Income Growth | 57.80% | 32.56% | -40.81% | 22.83% | 68.38% | Upgrade
|
Shares Outstanding (Basic) | 80 | 80 | 80 | 80 | 73 | Upgrade
|
Shares Outstanding (Diluted) | 80 | 80 | 80 | 80 | 73 | Upgrade
|
Shares Change (YoY) | 0.02% | - | - | 9.97% | - | Upgrade
|
EPS (Basic) | 23.35 | 14.80 | 11.16 | 18.86 | 16.89 | Upgrade
|
EPS (Diluted) | 23.35 | 14.80 | 11.16 | 18.86 | 16.89 | Upgrade
|
EPS Growth | 57.77% | 32.62% | -40.83% | 11.68% | 68.38% | Upgrade
|
Free Cash Flow | 22.99 | -323.48 | -443.05 | -111.03 | 276.48 | Upgrade
|
Free Cash Flow Per Share | 0.29 | -4.02 | -5.50 | -1.38 | 3.78 | Upgrade
|
Dividend Per Share | 1.000 | 0.800 | 0.600 | 0.600 | 0.540 | Upgrade
|
Dividend Growth | 25.00% | 33.33% | - | 11.11% | -73.00% | Upgrade
|
Gross Margin | 69.68% | 59.28% | 57.46% | 61.61% | 66.03% | Upgrade
|
Operating Margin | 34.51% | 28.09% | 25.42% | 38.55% | 42.53% | Upgrade
|
Profit Margin | 26.99% | 20.88% | 19.49% | 28.64% | 31.59% | Upgrade
|
Free Cash Flow Margin | 0.33% | -5.67% | -9.61% | -2.10% | 7.07% | Upgrade
|
EBITDA | 2,608 | 1,752 | 1,281 | 2,136 | 1,724 | Upgrade
|
EBITDA Margin | 37.45% | 30.72% | 27.80% | 40.31% | 44.06% | Upgrade
|
D&A For EBITDA | 204.44 | 149.62 | 109.7 | 93.01 | 60 | Upgrade
|
EBIT | 2,404 | 1,602 | 1,172 | 2,043 | 1,664 | Upgrade
|
EBIT Margin | 34.51% | 28.09% | 25.42% | 38.55% | 42.53% | Upgrade
|
Effective Tax Rate | 24.36% | 28.11% | 27.23% | 26.75% | 26.13% | Upgrade
|
Revenue as Reported | 7,063 | 5,810 | 4,704 | 5,376 | 3,962 | Upgrade
|
Advertising Expenses | - | 185.39 | 173.92 | 165.03 | 173.8 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.